| mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.05 |
| mRNA |
lenalidomide |
GDSC1000 |
pan-cancer |
AAC |
0.08 |
0.05 |
| mRNA |
GW-405833 |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.05 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.05 |
| mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.05 |
| mRNA |
ATRA |
GDSC1000 |
pan-cancer |
AAC |
0.075 |
0.05 |
| mRNA |
VX-11e |
GDSC1000 |
pan-cancer |
AAC |
-0.073 |
0.05 |
| mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.05 |
| mRNA |
Camptothecin |
GDSC1000 |
pan-cancer |
AAC |
0.075 |
0.05 |
| mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.06 |